Follow-up of the adult patient after transplantation

Acta Gastro-Enterologica Belgica

Volumn 62, Issue 3, 1999, Pages 348-354

  Neuberger, J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; LIPID; MYCOPHENOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; ORAL POLIOMYELITIS VACCINE; POTASSIUM SPARING DIURETIC AGENT; PREDNISOLONE; RAPAMYCIN; SEX HORMONE; TACROLIMUS; TRIACYLGLYCEROL;

BONE NECROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DIABETES MELLITUS; FOLLOW UP; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FAILURE; LIVER BIOPSY; LIVER FAILURE; LIVER INJURY; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MORTALITY; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; OSTEOPENIA; PATIENT COMPLIANCE; POSTOPERATIVE COMPLICATION; PREGNANCY; QUALITY OF LIFE; RECURRENT DISEASE; SEPSIS;

EID: 0032824606     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. ANAND A., HUBSCHER S.G., GUNSON B., MCMASTER P., NEUBERGER J. Timing, significance and prognosis of late acute liver allograft rejection. Transplantation, 1995, 60 : 1098-1103.
2. NEUBERGER J., WILSON P., ADAMS D. Protocol liver biopsies : the case in favour. Transplantation Proceedings, 1998, 30 : 1497-1499.
3. PADBURY R.T.A., TOOGOOD G., MCMASTER P. Withdrawal of immunosuppression in liver allograft recipients. Liver Transplantation and Surgery, 1998, 4 : 242-248.
4. SCHWEIZER R.T., ROVELLI M., PALMERI D., VOSSLER E., HULL D., BARTUS S. Non-compliance in organ transplant recipients. Transplantation, 1990, 49 : 374-377.
5. MOR E., GONWA T.A., HUSBERG B.S., GOLDSTEIN R.M. Late-onset acute rejection in orthotopic liver transplantation - associated risk factors and outcome. Transplantation, 1992, 54 : 821-824.
6. FISHER N.C., NIGHTINGALE P.G., GUNSON B., LIPKIN G., NEUBERGER J. Chronic renal failure following liver transplantation. Transplantation, 1998, 66 : 59-66
7. PENN I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transplantation and Surgery, 1996, 2 : 52-59.
8. FREZZA E.E., FUNG J.J., VAN THIEL D. Non-lymphoid cancer after liver transplantation. Hepato-gastroenterology, 1998, 44 : 1172-1181.
9. CALDWELL S. H. Hard times and imperfect organs. Liver Transplantation and Surgery, 1997, 3 : 181-184.
10. CHAZOUILLERES O., MAMISH D., KIM M., CAREY K., FERRELL, ROBERTS J., WRIGHT T. "Occult" hepatitis B virus as a source of infection in liver transplant recipients. Lancet, 1994, 343 : 142-146.
11. GOFF J.S., GLAZNER J., BILIR B. Measuring outcome after liver transplantation : a critical review. Liver Transplantation and Surgery, 1998, 4: 189-196
12. BELLE S.H., PORAYKO M.K., HOOFNAGLE J., LAKE J.R., ZETTERMAN R.K. for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD). Liver Transplantation and Surgery, 1997, 3 : 93-104.
13. BRYAN S., RATCLIFFE J., NEUBERGER J., BURROUGHS A., GUNSON B., BUXTON M. An assessment of patients' quality of life following liver transplantation. Quality of Life Research, 1998, 7 : 15-120.
14. LAIFER S.A., GUIDO R.S. Reproductive function and outcome of pregnancy after liver transplantation in women. Mayo Clinic Proceedings, 1995, 70 : 388-394.
15. ARMENTI V.T., RADOMSKI J.S., MORITZ MJ. Parenthood after liver transplantation. Liver Transplantation and Surgery, 1995, 1 (suppl 1) : 84-88.
16. CASELE H.E., LAIFER S.A. Association of pregnancy complications and choice of immunosuppressant in liver transplant patients. Transplantation, 1998, 65 : 581-583.
17. JAIN A., VENKATARAMANAN R., FUNG J.J., GARTNER J.C., LEVER J., BALAN V., WARTY V., STARZL T.E. Pregnancy after liver transplantation under tacrolimus. Transplantation, 1997, 64 : 559-565.
18. KRENTZ A.J., CRAMB R., DOUSSET B., MAYER A.D., MCMASTER P., BUCKELS J.A.C., NATTRASS M. Serum lipid and apolipoproteins in liver transplant recipients : a comparative study of cyclosporin A and FK506. J. Lab. Clin. Med., 1994, 124 : 381-385
19. JINDAL R.M., POPESCU I., EMRE S., SCHWARTZ M.E., BOCCAGNI P., MENESES P. et al. Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporin versus FK506. Transplantation, 1994, 57 : 1395-1398
20. CANZANELLO V.J., SCHWARTZ L., TALER S., TEXTOR S.C., WIESNER R.H., PORAYKO M.K., KROM R.A.F. Evolution of cardiovascular risk after liver transplantation : a comparison of cyclosproine A and tacrolimus (FK506). Liver Transplantation and Surgery, 1997, 3 : 1-9.
21. ABOULJOUD M.S., LEVY M.F., KLINTMALM G.B. and the US Multicenter Study Group. Hyperlipidaemia after liver transplantation : long-term results of the FK506/cyclosporine A US multicenter trial. Transplant Proc., 1995. 27 : 1121-1123.
22. LOSS M., WINKLER M., SCHNEIDER A., BRINKMAN C., MANNS M., RINGE B. et al. Influence of long-term cyclosporine or FK506 therapy on glucose and lipid metabolism in stable liver graft recipients. Transplant Proc., 1995, 27 : 1136-1139.
23. PAPATHEODORIDIS G.V., HAMILTON M., ROLLES K., BURROUGHS A. Liver Transplantation and inflammatory bowel disease. Journal of Hepatology, 1998, 28 : 1070-1076.